Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Sanofi-aventis and Medicines for Malaria Venture Join Forces to Develop Innovative Malaria Drugs
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Novartis gains FDA approval for Afinitor®
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
FDA approves linagliptin tablets for the treatment of type 2 diabetes
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Pfizer Reports First-Quarter 2011 Results
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Bayer off to a successful start to 2011
- Pfizer Announces Top-Line Results of Final Two Pivotal Phase 3 Trials of Tofacitinib (CP-690,550)
- Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval
- Genzyme Revenues Grow in First-Quarter 2011
- Shire delivers a strong first quarter performance
- Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease
- Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005